Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR

Genes and Development

Volumn 11, Issue 3, 1997, Pages 289-298

  Willy, Patricia J ^a   Mangelsdorf, David J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

heterodimers; LXR; nuclear receptors; retinoid receptors; RXR; trans activation domain

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; RETINOID; RETINOID X RECEPTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA BINDING; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSACTIVATION;

EID: 0031042762     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.3.289     Document Type: Article

References (45)

1. Baniahmad, A., X. Leng, T.P. Burris, S.Y. Tsai, M.-J. Tsai, and B.W. O'Malley. 1995. The τ4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15: 76-86.
2. Barettino, D., M.D.M.V. Ruiz, and H.G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13: 3039-3049.
3. Boehm, M.F., L. Zhang, B.B. Badea, S.K. White, D.E. Mais, E. Berger, C.M. Suto, M.E. Goldman, and R.A. Heyman. 1994. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem. 37: 2930-2941.
4. Cavaillés, V., S. Cauvois, F. L'Horset, G. Lopez, S. Hoare, P.J. Kushner, and M.G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation hy the estrogen receptor. EMBO J. 14: 3741-3751.
5. Chen, J.D. and R.M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
6. Danielian, P.S., R. White, J.A. Lees, and M.G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11: 1025-1033.
7. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13: 5370-5382.
8. Forman, B.M., K. Umesono, J. Chen, and R.M. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81: 541-550.
9. Giguère, V., E.S. Ong, P. Segui, and R.M. Evans. 1987. Identification of a receptor for the morphogen retinoic acid. Nature 330: 624-629.
10. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription. Science 264: 1455-1458.
11. Harmon, M.A., M.F. Boehm, R.A. Heyman, and D.J. Mangelsdorf. 1995. Activation of mammalian retinoid X receptors by the insect growth regulator methoprene. Proc. Natl. Acad. Sci. 92: 6157-6160.
12. Hollenberg, S.M. and R.M. Evans. 1988. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55: 899-906.
13. Hörlein, A.J., A.M. Näär, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Söderström, C.K. Glass, and M.G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404.
14. Katz, R.W. and R.J. Koenig. 1994. Nucleotide substitutions differentially affect direct repeat and palindromic thyroid hormone response elements. J. Biol Chem. 269: 9500-9505.
15. Kurokawa, R., V.C. Yu, A. Näär, S. Kyakumoto, Z. Han, S. Silverman, M.G. Rosenfeld, and C.K. Glass. 1993. Differential orientations of the DNA-binding domain and carboxy-termi-nal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes & Dev. 7: 1423-1435.
16. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M.G. Rosenfeld, R.A. Heyman, and C.K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371: 528-531.
17. Kurokawa, R., M. Söderström, A.J. Hörlein, S. Halachmi, M. Brown, M.G. Rosenfeld, and C.K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377: 451-454.
18. Le Douarin, B., C. Zechel, J.M. Garnier, Y. Lutz, L. Tora, B. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14: 2020-2033.
19. Leblanc, B.P. and H.G. Stunnenherg. 1995. 9-Cis retinoic acid signaling: Changing partners causes some excitement. Genes & Dev. 9: 1811-1816.
20. Lee, J.W., F. Ryan, J.C. Swaffield, S.A. Johnston, and D.D. Moore. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374: 91-94.
21. Leng, X., J. Blanco, S.Y. Tsai, K. Ozato, B.W. O'Malley, and M.-J. Tsai. 1995. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. Cell. Biol. 15: 255-263.
22. Mader, S., P. Leroy, J.-Y. Chen, and P. Chambon. 1993. Multiple parameters control the selectivity of nuclear receptors for their response elements: Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. J. Biol. Chem. 268: 591-600.
23. Mangelsdorf, D.J. and R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841-850.
24. Mangelsdorf, D.J., E.S. Ong, J.A. Dyck, and R.M. Evans. 1990. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224-229.
25. Mangelsdorf, D.J., K. Umesono, S.A. Kliewer, U. Borgmeyer, E.S. Ong, and R.M. Evans. 1991. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66: 555-561.
26. Mangelsdorf, D.J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
27. McKnight, S.L. 1996. Transcription revisited: A commentary on the 1995 Cold Spring Harbor laboratory meeting, "Mechanisms of eukaryotic transcription." Genes & Dev. 10: 367-381.
28. Nagpal, S., M. Saunders, P. Kastner, B. Durand, H. Nakshatri, and P. Chambon. 1992. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70: 1007-1019.
29. Nagpal, S., S. Friant, H. Nakshatri, and P. Chambon. 1993. RARs and RXRs: Evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J. 12: 2349-2360.
30. Onate, S.A., S.Y. Tsai, M.J. Tsai, and B.W. O'Mallcy. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
31. Perlmann, T. and L. Jansson. 1995. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes & Dev. 9: 769-782.
32. Perlmann, T., P.N. Rangarajan, K. Umesono, and R.M. Evans. 1993. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes & Dev. 7: 1411-1422.
33. Renaud, J.P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378: 681-689.
34. Roy, B., R. Taneja, and P. Chambon. 1995. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor a (RARα)-, RARβ-, or RARα-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell. Biol. 15: 6481-6487.
35. Saatcioglu, F., P. Bartunek, T. Deng, M. Zenke, and M. Karin. 1993. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol. Cell. Biol. 13: 3675-3685.
36. 3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell. Biol. 15: 1154-1161.
37. Schulman, I.G., D. Chakravarti, H. Juguilon, A. Romo, and R.M. Evans. 1995. Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation. Proc. Natl. Acad. Sci. 92: 8288-8292.
38. Strähle, U., G. Kolck, and G. Schütz. 1987. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc. Natl. Acad. Sci. 84: 7871-7875.
39. Tone, Y., M.A. Collingwood, M. Adams, and V.K. Chatterjee. 1994. Functional analysis of a transactivation domain in the thyroid hormone β receptor. J. Biol. Chem. 269: 31157-31161.
40. 3 receptors. Cell 65: 1255-1266.
41. vom Baur, E., C. Zechel, D. Heery, M. Heine, J.M. Garnier, V. Vivat, B. Le Douarin, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcnptional intermediary factors mSUG1 and TIF1. EMBO J. 15: 110-124.
42. Webster, N.J.G., S. Green, J.R. Jin, and P. Chambon. 1988. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54: 199-207.
43. Weinberger, C., C.C. Thompson, E.S. Ong, R. Lebo, D.J. Gruol, and R.M. Evans. 1986. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324: 641-646.
44. Willy, P.J., K. Umesono, E.S. Ong, R.M. Evans, R.A. Heyman, and D.J. Mangelsdorf. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes & Dev. 9: 1033-1045.
45. Zhang, X.-K., G. Salben, M.-O. Lee, and M. Pfahl. 1994. Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor. Mol. Cell. Biol. 14: 4311-4323.